131 related articles for article (PubMed ID: 7736515)
1. Effect of a bifunctional monoclonal antibody directed against a tumor marker and doxorubicin on the growth of epidermoid vulvar carcinoma grafted in athymic mice.
Morelli D; Ménard S; Pozzi B; Balsari A; Colnaghi MI
Cell Biophys; 1994; 24-25():119-26. PubMed ID: 7736515
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
Baselga J; Norton L; Masui H; Pandiella A; Coplan K; Miller WH; Mendelsohn J
J Natl Cancer Inst; 1993 Aug; 85(16):1327-33. PubMed ID: 8340945
[TBL] [Abstract][Full Text] [Related]
3. Modulation of drug-induced cytotoxicity by a bispecific monoclonal antibody that recognizes the epidermal growth factor receptor and doxorubicin.
Morelli D; Sardini A; Villa E; Villa ML; Ménard S; Colnaghi MI; Balsari A
Cancer Immunol Immunother; 1994 Mar; 38(3):171-7. PubMed ID: 8124685
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin conjugated with a monoclonal antibody directed to a human melanoma-associated proteoglycan suppresses the growth of established tumor xenografts in nude mice.
Yang HM; Reisfeld RA
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1189-93. PubMed ID: 3422487
[TBL] [Abstract][Full Text] [Related]
5. Relevance of antibody valency in EGF receptor modulation.
Morelli D; Villa E; Tagliabue E; Perletti L; Villa ML; Ménard S; Balsari A; Colnaghi MI
Scand J Immunol; 1994 May; 39(5):453-8. PubMed ID: 8191221
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction.
Modjtahedi H; Eccles S; Box G; Styles J; Dean C
Br J Cancer; 1993 Feb; 67(2):254-61. PubMed ID: 7679281
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human tumor growth in nude mice by a conjugate of doxorubicin with monoclonal antibodies to epidermal growth factor receptor.
Aboud-Pirak E; Hurwitz E; Bellot F; Schlessinger J; Sela M
Proc Natl Acad Sci U S A; 1989 May; 86(10):3778-81. PubMed ID: 2786202
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth.
Harwerth IM; Wels W; Schlegel J; Müller M; Hynes NE
Br J Cancer; 1993 Dec; 68(6):1140-5. PubMed ID: 7903153
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition of xenotransplanted human carcinomas by a monoclonal antibody directed against the epidermal growth factor receptor.
Schnürch HG; Stegmüller M; Vering A; Beckmann MW; Bender HG
Eur J Cancer; 1994; 30A(4):491-6. PubMed ID: 8018408
[TBL] [Abstract][Full Text] [Related]
10. The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.
Modjtahedi H; Styles JM; Dean CJ
Br J Cancer; 1993 Feb; 67(2):247-53. PubMed ID: 8094290
[TBL] [Abstract][Full Text] [Related]
11. Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody.
Goldenberg A; Masui H; Divgi C; Kamrath H; Pentlow K; Mendelsohn J
J Natl Cancer Inst; 1989 Nov; 81(21):1616-25. PubMed ID: 2795690
[TBL] [Abstract][Full Text] [Related]
12. An anti-doxorubicin monoclonal antibody modulates kinetic and dynamic characteristics of the drug.
Sardini A; Villa E; Morelli D; Ghione M; Ménard S; Colnaghi MI; Balsari A
Int J Cancer; 1992 Feb; 50(4):617-20. PubMed ID: 1537626
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.
Desrues B; Léna H; Brichory F; Ramée MP; Toujas L; Delaval P; Dazord L
Br J Cancer; 1995 Nov; 72(5):1076-82. PubMed ID: 7577450
[TBL] [Abstract][Full Text] [Related]
14. Dual mode of action of a human anti-epidermal growth factor receptor monoclonal antibody for cancer therapy.
Bleeker WK; Lammerts van Bueren JJ; van Ojik HH; Gerritsen AF; Pluyter M; Houtkamp M; Halk E; Goldstein J; Schuurman J; van Dijk MA; van de Winkel JG; Parren PW
J Immunol; 2004 Oct; 173(7):4699-707. PubMed ID: 15383606
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.
Masui H; Kawamoto T; Sato JD; Wolf B; Sato G; Mendelsohn J
Cancer Res; 1984 Mar; 44(3):1002-7. PubMed ID: 6318979
[TBL] [Abstract][Full Text] [Related]
16. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor efficacy of an anti-epidermal-growth-factor-receptor monoclonal antibody and its F(ab')2 fragment against high- and low-EGFR-expressing carcinomas in nude mice.
Tosi E; Valota O; Negri DR; Adobati E; Mazzoni A; Meazza R; Ferrini S; Colnaghi MI; Canevari S
Int J Cancer; 1995 Sep; 62(5):643-50. PubMed ID: 7665239
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
Cheng WW; Allen TM
J Control Release; 2008 Feb; 126(1):50-8. PubMed ID: 18068849
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
[TBL] [Abstract][Full Text] [Related]
20. Humanized versus murine anti-human epidermal growth factor receptor monoclonal antibodies for immunoscintigraphic studies.
Morales AA; Ducongé J; Alvarez-Ruiz D; Becquer-Viart ML; Núñez-Gandolff G; Fernández E; Caballero-Torres I; Iznaga-Escobar N
Nucl Med Biol; 2000 Feb; 27(2):199-206. PubMed ID: 10773550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
